Clinical trial
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic…
NCT00381095 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Terminated
Key facts
| NCT number | NCT00381095 |
|---|---|
| Title | A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer |
| Official title | A Randomized Placebo-Controlled Trial Of The Efficacy And Tolerability Of Flexibly Dosed Pregabalin In The Treatment Of Cancer-Induced Bone Pain |
| Acronym | COPE |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bone Neoplasms, Pain, Intractable, Cancer |
| Intervention type | Drug |
| Interventions | Pregabalin, Placebo |
| Enrollment | 152 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Sep 27, 2006 |
| Last update posted | Jan 20, 2021 |
| Countries | Canada, Czechia, Egypt, Finland, France, Hungary, Italy, Mexico, Peru, Philippines, Poland, Russia and 7 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: